This inventor holds 1 USPTO granted patent. Top assignee: Ucbbiopharma Srl. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Pfrafulkumar Tulshibhai Chovatia: Innovator in Allergy Treatment
Introduction
Pfrafulkumar Tulshibhai Chovatia is a notable inventor based in Oxfordshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of disorders caused by IgE. His innovative work has led to the development of valuable compounds that address various allergic conditions.
Latest Patents
Chovatia holds a patent for "Thiophene derivatives for the treatment of disorders caused by IgE." This patent includes thiophene derivatives of formula (I) and pharmaceutically acceptable salts. These compounds are designed to treat or prevent disorders caused by IgE, such as allergies, type 1 hypersensitivity, and familiar sinus inflammation. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Chovatia is associated with UCB Biopharma Srl, where he continues to work on innovative solutions in the pharmaceutical industry. His research focuses on developing effective treatments for allergic disorders, contributing to improved patient outcomes.
Collaborations
Chovatia collaborates with esteemed colleagues, including Rickki Lee Connelly and Richard Jeremy Franklin. Their combined expertise enhances the research and development efforts within their organization.
Conclusion
Pfrafulkumar Tulshibhai Chovatia is a dedicated inventor whose work in allergy treatment exemplifies innovation in the pharmaceutical field. His contributions are paving the way for new therapeutic options for patients suffering from IgE-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile